Overview

Dose Linearity Study of Codeine Sulfate Under Fasted Conditions

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to examine the dose linearity of Roxane Laboratories' 15 mg, 30 mg, and 60 mg codeine sulfate tablets under fasted conditions
Phase:
Phase 1
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Codeine